Abstract:In the current scenario, the available drugs for SARS-CoV-2 are extremely limited. Among the potential therapeutic targets, the RNA-dependent RNA polymerase (RdRp) complex, essential for viral replication and transcription, presents a promising focal point for drug design. This study explores the mechanistic effects of chemically modified nucleoside analogs on the activity of SARS-CoV-2 RdRp and the subsequent chain termination of viral RNA synthesis. We investigate a range of modifications, including 2'-fluoro (2'-F), 2'-O-methyl, and 3'-deoxy substitutions on the sugar as well as base component changes, to ascertain their incorporation by RdRp and resistance to proofreading by the nsp14/nsp10 exonuclease complex. Through a combination of enzymatic experiments, we elucidate the influence of these modifications on RdRp efficiency. Our findings demonstrate that 2'-OMe-NTP, 3'-dNTP, 6-Aza-UTP can enhance the likelihood of chain termination, offering insights into the design of nucleoside analogs with potent antiviral activities. The study's comprehensive analysis not only furthers our understanding of SARS-CoV-2's molecular biology but also contributes to the strategic development of antiviral agents with the potential to combat the current pandemic and prepare for future coronavirus outbreaks.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to design effective antiviral drugs for the RNA - dependent RNA polymerase (RdRp) of the SARS - CoV - 2 virus. Specifically, the study aims to explore the effects of chemically modified nucleoside analogues on the activity of SARS - CoV - 2 RdRp and their mechanism of action in RNA chain termination. Through these studies, the authors hope to find nucleoside analogues that can effectively inhibit virus replication and resist the virus - proofreading mechanism, thereby developing new antiviral strategies. ### Main research contents: 1. **Chemical modification of nucleoside analogues**: - A variety of chemical modifications were studied, including glycosyl modifications such as 2' - fluoro (2' - F), 2' - O - methyl, 3' - deoxy, etc., as well as changes in the base part. - These modifications are aimed at enhancing the ability of nucleoside analogues to be recognized by RdRp and integrated into the viral RNA chain, and enabling them to resist the virus - proofreading mechanism. 2. **Effect on RdRp activity**: - The effects of nucleoside analogues with different chemical modifications on RdRp activity were evaluated through in vitro biochemical experiments. - The results showed that 2' - O - methyl, 3' - deoxy, and certain specific base modifications (such as 6 - Aza - UTP) could significantly affect the activity of RdRp, leading to immediate or delayed termination of RNA synthesis. 3. **Ability to resist the proofreading mechanism**: - These nucleoside analogues were further evaluated for their resistance to the nsp14/nsp10 exonuclease complex of SARS - CoV - 2. - It was found that 3' - deoxy nucleoside analogues have a relatively high resistance to the proofreading mechanism, while other modifications may be recognized and removed by the proofreading mechanism. ### Research significance: - **Design of antiviral drugs**: By deeply understanding the mechanism of action of these chemically modified nucleoside analogues, theoretical basis can be provided for the design of more effective anti - SARS - CoV - 2 drugs. - **Understanding of molecular biology**: The research results not only enhance the understanding of the molecular biology of SARS - CoV - 2, but also provide important references for future responses to coronavirus outbreaks. ### Key findings: - **2' - O - methyl and 3' - deoxy nucleoside analogues**: These modifications can immediately terminate the extension of the RNA chain, showing strong antiviral potential. - **6 - Aza - UTP**: This modification leads to delayed chain termination, indicating its interference with RdRp. - **3' - deoxy nucleoside analogues**: Have a relatively high resistance to the proofreading mechanism of the nsp14/nsp10 exonuclease complex and are important candidates for the development of antiviral drugs. In conclusion, this study provides important experimental data and theoretical support for the development of new anti - SARS - CoV - 2 drugs, which is helpful for promoting the development of antiviral therapy.

Chain Termination Effects of Chemically Modified Nucleoside Analogs on SARS-CoV-2 RNA Polymerase

2′- and 3′-Ribose Modifications of Nucleotide Analogues Establish the Structural Basis to Inhibit the Viral Replication of SARS-CoV-2

Nucleotide analogues as inhibitors of SARS-CoV Polymerase

Structural basis for inhibition of the RNA-dependent RNA polymerase from SARS-CoV-2 by remdesivir

Inhibition of SARS-CoV-2 polymerase by nucleotide analogs from a single-molecule perspective

Nucleotide Analogues as Inhibitors of SARS-CoV-2 Polymerase, a Key Drug Target for COVID-19

Development of a Simple in Vitro Assay to Identify and Evaluate Nucleotide Analogs Against SARS-CoV-2 RNA-Dependent RNA Polymerase

Exploring nucleoside analogs: key targets in the viral life cycle - advancing strategies against SARS-CoV-2

Binding Mechanism of Remdesivir to SARS-CoV-2 RNA Dependent RNA Polymerase

Developing nucleoside tailoring strategies against SARS-CoV-2 via ribonuclease targeting chimera

Assessing the inhibitory effects of some secondary amines, thioureas and 1,3-dimethyluracil conjugates of (-)-cytisine and thermopsine on the RNA-dependent RNA polymerase of SARS-CoV-1 and SARS-CoV-2

Structural Basis for RNA Replication by the SARS-CoV-2 Polymerase

A Mechanism for SARS-CoV-2 RNA Capping and Its Inhibition by Nucleotide Analog Inhibitors.

Structural basis for repurpose and design of nucleoside drugs for treating COVID-19

A Cell-Based Assay to Discover Inhibitors of SARS-CoV-2 RNA Dependent RNA Polymerase.

Identifying Small-Molecule Inhibitors of SARS-CoV-2 RNA-Dependent RNA Polymerase by Establishing a Fluorometric Assay

Small-molecule inhibition of SARS-CoV-2 NSP14 RNA cap methyltransferase

Efficient Inhibition of SARS‐CoV‐2 Using Chimeric Antisense Oligonucleotides Through RNase L Activation**

Nucleotide Analogues Bearing a C2′ or C3′-Stereogenic All-Carbon Quaternary Center as SARS-CoV-2 RdRp Inhibitors

Evaluating the potential of different inhibitors on RNA-dependent RNA polymerase of severe acute respiratory syndrome coronavirus 2: A molecular modeling approach

Studying the intersection of nucleoside modifications and SARS-CoV-2 RNA-dependent RNA transcription using an in vitro reconstituted system